TREATMENT OF PATIENTS WITH VISCERAL CANDIDIASIS


如何引用文章

全文:

详细

Aim. To study effectiveness of antimycotic medication with flucostat in patients with visceral candidiasis.
Material and methods. Diagnosis of bronchopulmonary, gastrointestinal, urogenital candidiasis was
verified microbiologically in 152 patients aged 20 to 78 years. Candidiasis was treated with flucostat:
50 mg and 150 mg capsules per os and solution (100-50 ml) intravenously by dropper.
Results. The response was achieved in 140 (92.1%) patients: cure - in 107 (70.4%), improvement in 33 (21.7%),
mycological sanation - in 125 (82.2%) patients.
Conclusion. Cure of chronic diseases complicated by mycotic infection is not always achieved after
mycotic sanation. Some symptoms of severe chronic pathology persist and require long-term symptomatic
treatment.

作者简介

G Makova

Городская клиническая больница № 81, Москва

Городская клиническая больница № 81, Москва

I Kurbatova

Городская клиническая больница № 81, Москва

Городская клиническая больница № 81, Москва

参考

  1. Бурова С. А. Проблемы грибковых заболеваний человека. Рос. журн. кож. и вен. бол. 1998; 1: 39-41.
  2. Ли Е., Biskel R. H., Baldauf G. Pulmonary Candida manifestation with cavitation in immunosuppressed patients. Radiologe 1987; 27 (1): 25-28.
  3. Cassone A. Cell-mediated immunity mechanism in fungal infections. In: Jacobs P., Nail L., eds. Fungal disease. Biology, immunology and diagnosis. New York: Marcell Dekker; 1997. 130-131.
  4. Бурова С. А. Пневмомикозы. Тер. арх. 1998; 10: 68-71.

版权所有 © Consilium Medicum, 2003

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 
 


##common.cookie##